Bioiberica to present Hialsorb® Intraarticular and Tendoactive® at the 55th Congress of the SECOT
Bioberica will present their prescription, nutraceutical and injectable products at Booth #3
Once more, Bioiberica will be present at one of the main events nationwide in joint health and traumatology. The 55th SECOT Congress will be held from 26 to 28 September at the Miguel Delibes Auditorium in Valladolid, and will include a complete scientific program focusing on the most relevant issues in current orthopedic surgery and traumatology.
Bioberica’s joint health range is highly valued by traumatology experts, with which Bioiberica has been working very closely for over 20 years. This collaboration, together with other factors, has allowed us to develop scientifically proven solutions for osteoarthritis, joint injuries and musculoskeletal diseases.
Bioiberica’s highlighted products will be Hialsorb Intraarticular®, a hyaluronic acid injection prescribed for the treatment of degenerative or mechanical arthropathy associated with pain or reduced mobility, and Tendoactive®, a dietary supplement with an exclusive formulation for tendon care. Specialists attending booth #3 of the exhibitor’s area of the SECOT Congress will be provided with complete information on these products, as well as prescription drugs and other non pharmacological solutions for joint healthcare.
